Region Skåne Biobank

Region Skåne biobank is a central biobank with quality-assured sub-divisions. Today there are about 35 biobank departments with different disciplines.  The biobank contains many sample collections and over 20 million samples from the healthcare sector, for care, diagnostics, and treatment, as well as research sample collections, and omics data.

Key facts

Name of the connected EIT Health partner: Region Skåne
Number of individuals: Total ~500,000
Biobank confirmed willingness to provide samples/data for EIT Health studies: Region Skåne biobank contains many sample collections. The biobank has several sample collections that are saved for research purposes and sample collections saved primarily for health care. Samples saved for health and medical care can also be used for research, after ethics approval and permission from the biobank custodian. In order to gain access to samples that are part of research collections the applicant also has to obtain permission from the group or committee granting access to the respective samples.
Contact person(s) and contact data
(e-mail address, tel. no) for access purposes:
rbcsyd@skane.se Marie Sverud, RBC-chef Södra sjukvårdsregionen och Regional biobanks- och kvalitetssamordnare Region Skåne. Marie.b.sverud@skane.se
Number of samples: Total >20 million
Sample type: Region Skåne biobank is a biobank with quality-assured sub-divisions, so-called biobank departments. Today there are about 35 biobank departments with different disciplines and a combination sample samples collected in the healthcare sector for care, diagnostics and treatment and research sample collections.
Website: This varies in different collections.
Website: Region Skåne biobank

General information

Type of biobank: There are all kinds of sample collections.
If longitudinal the frequency: Not available.
Link to central portal to seek samples and data: https://biobanksverige.se/forskning/tillgang-till-prov-for-forskning/forskningsprovsamlingar/
Broad consent: Consent to save samples for future research.

Ethical consent in Sweden is rarely broad, and almost always linked to specific disease areas. Consent to participate in a study should always be informed and specified according to GDPR. A new approval from the Ethics Review Authority in Sweden is needed for each new study. They also assess whether the study can be covered by the already obtained consent or if new consent needs to be obtained.

Option to recall donors: Not available.
Option to recall family members: Not available.

Biobank access procedure:

Major terms for access: Samples can be made available to research groups and companies after a decision from the ethical review authority and after application to biobank custodian.
Ethical and legal compliance: To get access to samples from a collection or a cohort collected by researchers or research groups, applicant also must obtain permission from the group or committee granting access to the respective samples.
Speed and reliability of delivery: Not available.
Pricing: Not available.

Quality management system:

Link to operational procedure: Quality management system used in healthcare within the relevant laboratory.    https://vardgivare.skane.se/vardriktlinjer/laboratoriemedicin/#28992
Storage: Not available.
Compliance with international standards: Not available.
Current ISO certificates: Not available.


Clinical data linked to samples: This varies in different collections. Contact the biobank for specific information about which data is stored about the samples.
Data standards: Not available.
Data security rules: Not available.

Biobank related service:

Research support, what type of expertise?: Regulatory biobank service: http://www.rbcsyd.se/ and https://biobanksverige.se/kont/regionala-
Core facility services; what type? Link?: Operational biobank service, biobank facility, BD47,
in Region Skåne: https://vardgivare.skane.se/vardriktlinjer/laboratoriemedicin/
Queries from national health registers: Not available.
Links to the model contract and MTA: https://biobanksverige.se/research/getting-started/principles-of-access/


IP rules, what is negotiable?: Not available.
Requirements to study results (access etc.): Not available.
Participant’s right to the information: Not available.

COVID-19 samples:

Access to biological samples from patients with COVID-19?

  • Serum
  • Full blood (for RNA extraction)
  • EDTA-Full blood (for DNA extraction)
  • EDTA-Plasma
  • Citrate-Plasma
  • PBMC (Peripheral Blood Mononuclear Cells)
  • Nasopharyngeal aspirate
  • Tracheal aspirate
  • Serum
  • Blod
  • Urin

Samples from pregnant:

– Breast Milk
– Amniotic fluid
– Umbilical cord
– Swabs, pharynx, vaginal, rectal